ReviewPublished 12 October 2026Tumor antigens across cancer progression: from immune recognition and selection to precision cancer immunotherapyStanley P. LeongFrontiers in Immunologydoi 10.3389/fimmu.2026.1939919
ReviewPublished 12 October 2026Epigenetic rewiring of immunological memory in cancer: heterogeneity, mechanisms, and therapeutic vulnerabilitiesWenna Liu · Xiaole Pan · Yujia Zhao · Zhimei Li · Dan Wu · Ying LiangFrontiers in Immunologydoi 10.3389/fimmu.2026.1890189
Mini ReviewPublished 7 October 2026Pan-cancer biomarkers of immune therapy resistance: mechanisms and clinical translationChao Wang · Dong YangFrontiers in Cell and Developmental Biologydoi 10.3389/fcell.2026.1895670
Original ResearchPublished 16 September 2026Adoptive T Cell therapy for cancer and autoimmune disease: current advances, challenges, and future directionsQiu-Hong Bao · Angel Wu · Jianming Pang · Junwei Wang · Qingqing Chen · SuWen WuOncology Reviewsdoi 10.3389/or.2026.1905358
ReviewPublished 13 August 2026Functional genomics–guided design of CAR-T and CAR-NK therapies in hematological malignancies: aligning cellular engineering with immune escape and microenvironmental resistanceShiqi Cai · Yang Tan · Qian Yang · Juan HuangFrontiers in Genome Editingdoi 10.3389/fgeed.2026.1878460
ReviewPublished 23 June 2026The evolution of influenza hemagglutinin: structural numbering and receptor binding sites of influenza viruses capable of infecting humansMichael A. Carlock · Ted M. RossFrontiers in Virologydoi 10.3389/fviro.2026.1867727
ReviewPublished 30 April 2026Offense-defense in bone infection: interferon regulation and the immune evasion of Staphylococcus aureusJinrong Qian · Weiwei Qian · Xiaoyu Tang · Yin YangFrontiers in Bacteriologydoi 10.3389/fbrio.2026.1757036
